Literature DB >> 20801700

Gaucher disease and parkinsonism, a molecular link theory.

Ehud Goldin1.   

Abstract

Mutant GBA was found recently to be the most prevalent risk factor for familial parkinsonism. The two diseases do not share common symptoms and there is no direct pathway to explain the mechanism by which GBA mutations can confer the risk. Increased burden on the degradative pathway caused by defective glucocerebrosidase, or toxic side effects of glycosylated lipids accumulation were proposed to explain brain damage. Both hypotheses are not sufficient to explain the linkage. In order to develop a more inclusive theory we introduced into the model the prion theory and the second hit. Other possibilities are also brought into consideration.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801700      PMCID: PMC2991511          DOI: 10.1016/j.ymgme.2010.08.004

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  33 in total

1.  Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.

Authors:  U H Schueler; T Kolter; C R Kaneski; G C Zirzow; K Sandhoff; R O Brady
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Is Parkinson's disease a prion disorder?

Authors:  C Warren Olanow; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

Review 3.  Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.

Authors:  S B Prusiner
Journal:  Dev Biol Stand       Date:  1991

Review 4.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

Authors:  Vladimir N Uversky; David Eliezer
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

5.  The origin of fluorescence in the neuronal ceroid lipofuscinoses (Batten disease) and neuron cultures from affected sheep for studies of neurodegeneration.

Authors:  David N Palmer; Manfred J Oswald; Valerie J Westlake; Graham W Kay
Journal:  Arch Gerontol Geriatr       Date:  2002 May-Jun       Impact factor: 3.250

Review 6.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

Review 7.  Gaucher disease: complexity in a "simple" disorder.

Authors:  Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

8.  The influence of vesicle size and composition on alpha-synuclein structure and stability.

Authors:  Lars Kjaer; Lise Giehm; Thomas Heimburg; Daniel Otzen
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

9.  Red blood cells are the major source of alpha-synuclein in blood.

Authors:  Robin Barbour; Kristin Kling; John P Anderson; Kelly Banducci; Tracy Cole; Linnea Diep; Michael Fox; Jason M Goldstein; Ferdie Soriano; Peter Seubert; Tamie J Chilcote
Journal:  Neurodegener Dis       Date:  2008-01-04       Impact factor: 2.977

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  11 in total

Review 1.  Exploring the link between glucocerebrosidase mutations and parkinsonism.

Authors:  Wendy Westbroek; Ann Marie Gustafson; Ellen Sidransky
Journal:  Trends Mol Med       Date:  2011-07-01       Impact factor: 11.951

2.  CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.

Authors:  S Pablo Sardi; Jennifer Clarke; Cathrine Kinnecom; Thomas J Tamsett; Lingyun Li; Lisa M Stanek; Marco A Passini; Gregory A Grabowski; Michael G Schlossmacher; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

3.  A twelve-year follow-up study on a case of early-onset parkinsonism preceding clinical manifestation of Gaucher disease.

Authors:  Maciej Machaczka; Martin Paucar Arce; Malgorzata Rucinska; Takashi Yoshitake; Jan Kehr; Wojciech Jurczak; Aleksander B Skotnicki; Jan-Erik Månsson; Anna Tylki-Szymanska; Per Svenningsson
Journal:  JIMD Rep       Date:  2011-09-20

4.  Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.

Authors:  Thai Leong Yap; James M Gruschus; Arash Velayati; Wendy Westbroek; Ehud Goldin; Nima Moaven; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

5.  The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.

Authors:  Barry Rosenbloom; Manisha Balwani; Jeff M Bronstein; Edwin Kolodny; Swati Sathe; Andrea R Gwosdow; John S Taylor; J Alexander Cole; Ari Zimran; Neal J Weinreb
Journal:  Blood Cells Mol Dis       Date:  2010-11-10       Impact factor: 3.039

Review 6.  The link between the GBA gene and parkinsonism.

Authors:  Ellen Sidransky; Grisel Lopez
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

7.  Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.

Authors:  You-hai Xu; Kui Xu; Ying Sun; Benjamin Liou; Brian Quinn; Rong-hua Li; Ling Xue; Wujuan Zhang; Kenneth D R Setchell; David Witte; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2014-03-05       Impact factor: 6.150

Review 8.  Gaucher disease and the synucleinopathies: refining the relationship.

Authors:  Tessa N Campbell; Francis Y M Choy
Journal:  Orphanet J Rare Dis       Date:  2012-01-31       Impact factor: 4.123

9.  Fabry Disease With Concomitant Lewy Body Disease.

Authors:  Kelly Del Tredici; Albert C Ludolph; Simone Feldengut; Christian Jacob; Heinz Reichmann; Jürgen R Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2020-04-01       Impact factor: 3.685

10.  Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.

Authors:  Georgia Dermentzaki; Evangelia Dimitriou; Maria Xilouri; Helen Michelakakis; Leonidas Stefanis
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.